Literature DB >> 28208915

An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A Therapeutic Challenge.

S Sneha1, Shanthan Venishetty2, Shubha Seshadri3, M Sudhakar Rao4, Chiranjay Mukhopadhyay5.   

Abstract

Infective endocarditis by Methicillin Resistant Staphylococcus aureus (MRSA) bacteraemia is a common association and carries a high mortality. However, rising Minimum Inhibitory Concentrations (MICs) for vancomycin amongst MRSA strains is an emerging threat which carries poor prognosis and higher mortality. Here, we report a case of 41-year-old young non-addict gentleman presenting with fever of 3 days duration following recovery from an acute kidney injury necessitating haemodialysis. Systemic examination revealed signs of mitral regurgitation and left sided cerebellar signs. Laboratory investigations revealed anaemia, MRSA bacteraemia and transthoracic echocardiogram showed a mitral valve vegetation. He was diagnosed with MRSA mitral valve endocarditis with acute left cerebellar infarct. He was initially treated with intravenous vancomycin based on MIC at the dose of one gram every twelfth hourly. As the MRSA strain was shown to demonstrate a vancomycin creep phenomemon along with worsening clinical condition of the patient, treatment was changed to intravenous daptomycin at dose of 9mg/kg as per blood culture and sensitivity pattern which was administered for 6 weeks. Following initiation of daptomycin patient became afebrile and vegetations reduced in size and finally disappeared.

Entities:  

Keywords:  Daptomycin; Minimum inhibitory concentration; Mitral valve endocarditis

Year:  2016        PMID: 28208915      PMCID: PMC5296488          DOI: 10.7860/JCDR/2016/21709.9085

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?

Authors:  J Kehrmann; M Kaase; F Szabados; S G Gatermann; J Buer; P-M Rath; J Steinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-13       Impact factor: 3.267

Review 2.  Native valve right sided infective endocarditis.

Authors:  Karolina Akinosoglou; Efstratios Apostolakis; Markos Marangos; Geoffrey Pasvol
Journal:  Eur J Intern Med       Date:  2013-01-28       Impact factor: 4.487

3.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

4.  Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.

Authors:  José M Miro; Ignasi Anguera; Christopher H Cabell; Anita Y Chen; Judith A Stafford; G Ralph Corey; Lars Olaison; Susannah Eykyn; Bruno Hoen; Elias Abrutyn; Didier Raoult; Arnold Bayer; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2005-07-06       Impact factor: 9.079

5.  Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.

Authors:  Pak-Leung Ho; Pui-Ying Lo; Kin-Hung Chow; Eric H Y Lau; Eileen L Lai; Vincent C C Cheng; Richard Y Kao
Journal:  J Infect       Date:  2009-12-02       Impact factor: 6.072

6.  Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.

Authors:  Manuel L Fernández Guerrero; Julio J González López; Ana Goyenechea; Julián Fraile; Miguel de Górgolas
Journal:  Medicine (Baltimore)       Date:  2009-01       Impact factor: 1.889

7.  The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA.

Authors:  Katie E Barber; Brian J Werth; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2014-09-22       Impact factor: 5.790

8.  Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.

Authors:  Gregory Steinkraus; Roger White; Lawrence Friedrich
Journal:  J Antimicrob Chemother       Date:  2007-07-10       Impact factor: 5.790

9.  Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  Marie-Laure Foucault; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

10.  Eustachian valve endocarditis: Rare case reports and review of literature.

Authors:  Gaurav Alreja; Amir Lotfi
Journal:  J Cardiovasc Dis Res       Date:  2011-07
View more
  1 in total

1.  Assessment of Vancomycin MIC Creep Phenomenon in Methicillin-Resistant Staphylococcus aureus isolates in a Tertiary Care Hospital of Lahore.

Authors:  Faiqa Arshad; Sidrah Saleem; Shah Jahan; Romeeza Tahir
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.